Ponatinib in childhood Philadelphia chromosome –positive leukaemias: an international registry of childhood chronic myeloid leukaemia study

Ponatinib is effective in adults with Philadelphia chromosome –positive (Ph+) leukaemias, but scant data are available regarding the use of this tyrosine kinase inhibitor in children.

Source: European Journal of Cancer - July 11, 2020 Category: Cancer & Oncology Authors: Fr édéric Millot, Meinolf Suttorp, Anne B. Versluys, Krzysztof Kalwak, Brigitte Nelken, Stephane Ducassou, Yves Bertrand, André Baruchel Tags: Original Research Source Type: research